Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirus

Award Number: F32AI194777
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 11/01/2025
PERIOD OF PERFORMANCE END DATE: 10/31/2028

Group Awards By:

View Award Description

Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirus - Project Summary Capsid assembly is an essential step in production of an infectious herpesvirus, yet little is known on how the process begins and the protein oligomeric states and intermediate interactions required to complete the final mature capsid. Disruptions in capsid assembly result in aberrant capsids unable to assemble or package viral DNA, resulting in noninfectious virus. The major proteins involved in herpesvirus capsid assembly are generally conserved across alpha, beta, and gammaherpesvirus subfamilies which provides an opportunity to develop pan-herpesvirus therapeutics. Yet to date, little has been done to capitalize on this process; furthermore, most capsid assembly research focuses on alphaherpesvirus, HSV-1. This proposal focuses on understanding capsid assembly of gammaherpesvirus, Kaposi sarcoma herpesvirus (KSHV), the leading cause of cancer in HIV positive individuals. I will develop an in-vitro capsid assembly assay to monitor capsid kinetics and oligomeric states required for capsid nucleation and maturation. I hypothesize KSHV capsid assembly is a highly dynamic process requiring multiple conformations of capsid protein intermediates to generate a capsid capable of packaging a large DNA genome. I will purify KSHV capsid proteins via baculovirus expression and systematically determine the proteins required for capsid formation and kinetics via dynamic light scattering and negative stain electron microscopy. In addition, I will evaluate the oligomeric states of capsid proteins individually and protein intermediates to determine 1. The proteins required for capsid nucleation and 2. How KSHV scaffold oligomerizes to produce unique B-capsid morphologies. I further hypothesize that the divergence of SCP between subfamilies is a result of variations in the capsid assembly pathway. For example, it is thought SCP is not required for alphaherpesvirus capsid assembly but is required for gamma and betaherpesviruses. I hypothesize SCP is required for efficient C-capsid assembly, as loss of SCP results in decreased infectious virus and C-capsid formation in alpha, beta, and gammaherpesvirses; however, the exact mechanism is unclear and seems dependent on cellular environment. I will use the in-vitro capsid assemble assay and live virus mutagenesis to study the function of SCP in capsid maturation. I will utilize previously generated KSHV SCP null viruses to quantify capsid structural integrity with atomic force microscopy to determine at what stage capsid assembly stalls, as well as the role of phosphorylation on SCP’s function. These aims will highlight the similarities and difference between alpha and gammaherpevirus viruses, providing the evidence required for inhibitor development and a scalable in-vitro assay for testing inhibitors. I will develop a robust skillset in biophysical techniques which coupled with my expertise in molecular virology will allow me to successful complete these aims and develop the skills required to run my own independent research lab.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	001	1	1/2/2026	NEW	$0
2026	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	1	1/2/2026	NEW	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $78,052 )
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	1	8/29/2025	NEW	$78,052
														Subtotal = $78,052

Grand Total All Awards = $78,052

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirus

Award Number: F32AI194777

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 11/01/2025

PERIOD OF PERFORMANCE END DATE: 10/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer